Sandra Duquesne

Freiburg, BW, Germany

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 21 publications

FLT3-ITD Induces CMTM6 and Enhances Immune Escape in Acute Myeloid Leukemia.

FLT3-ITD Induces CMTM6 and Enhances Immune Escape in Acute Myeloid Leukemia.

Journal: Cancer research

Published: January 27, 2025

Adiponectin reduces immune checkpoint inhibitor-induced inflammation without blocking anti-tumor immunity.

Adiponectin reduces immune checkpoint inhibitor-induced inflammation without blocking anti-tumor immunity.

Journal: Cancer cell

Published: July 01, 2024

Anti-PD-1 cancer immunotherapy induces central nervous system immune-related adverse events by microglia activation.

Anti-PD-1 cancer immunotherapy induces central nervous system immune-related adverse events by microglia activation.

Journal: Science translational medicine

Published: June 12, 2024

Oncogenic Calreticulin Induces Immune Escape by Stimulating TGFβ Expression and Regulatory T-cell Expansion in the Bone Marrow Microenvironment.

Oncogenic Calreticulin Induces Immune Escape by Stimulating TGFβ Expression and Regulatory T-cell Expansion in the Bone Marrow Microenvironment.

Journal: Cancer research

Published: November 10, 2023

Oncogene-induced TIM-3 ligand expression dictates susceptibility to anti-TIM-3 therapy in mice.

Oncogene-induced TIM-3 ligand expression dictates susceptibility to anti-TIM-3 therapy in mice.

Journal: The Journal of clinical investigation

Published: November 08, 2023

Phase II trial of hypomethylating agent combined with nivolumab for acute myeloid leukaemia relapse after allogeneic haematopoietic cell transplantation-Immune signature correlates with response.

Phase II trial of hypomethylating agent combined with nivolumab for acute myeloid leukaemia relapse after allogeneic haematopoietic cell transplantation-Immune signature correlates with response.

Journal: British journal of haematology

Published: June 03, 2023

Targeting TGFβ-activated kinase-1 activation in microglia reduces CAR T immune effector cell-associated neurotoxicity syndrome.

Targeting TGFβ-activated kinase-1 activation in microglia reduces CAR T immune effector cell-associated neurotoxicity syndrome.

Journal: Nature cancer

Published: April 18, 2023

MDM2 Inhibition Enhances Immune Checkpoint Inhibitor Efficacy by Increasing IL15 and MHC Class II Production.

MDM2 Inhibition Enhances Immune Checkpoint Inhibitor Efficacy by Increasing IL15 and MHC Class II Production.

Journal: Molecular cancer research : MCR

Published: November 09, 2022

Targeting MDM2 enhances antileukemia immunity after allogeneic transplantation via MHC-II and TRAIL-R1/2 upregulation.

Targeting MDM2 enhances antileukemia immunity after allogeneic transplantation via MHC-II and TRAIL-R1/2 upregulation.

Journal: Blood

Published: February 24, 2022

ROCK1/2 signaling contributes to corticosteroid-refractory acute graft-versus-host disease.

ROCK1/2 signaling contributes to corticosteroid-refractory acute graft-versus-host disease.

Journal: Nature communications

Published: April 18, 2020

Oncogenic KrasG12D Activation in the Nonhematopoietic Bone Marrow Microenvironment Causes Myelodysplastic Syndrome in Mice.

Oncogenic KrasG12D Activation in the Nonhematopoietic Bone Marrow Microenvironment Causes Myelodysplastic Syndrome in Mice.

Journal: Molecular cancer research : MCR

Published: March 25, 2020

Metabolic reprogramming of donor T cells enhances graft-versus-leukemia effects in mice and humans.

Metabolic reprogramming of donor T cells enhances graft-versus-leukemia effects in mice and humans.

Journal: Science translational medicine

Published: March 25, 2020

Showing 1-12 of 21

Last Updated: 09/26/2026